MKPL
M K Proteins financials
- Market cap
- ₹151 Cr
- Sector
- Fast Moving Consumer Goods
Quarterly results
Q1 FY27: revenue up 0.2%, net profit down 60.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 34 | 39 | 137 | 115 | 32 −4% | 90 +127% | 146 +6% | 115 +0% |
| EBITDA | 2 | 2 | 5 | 6 | 1 −53% | 2 +32% | 3 −46% | 3 −54% |
| Net profit | 2 | 1 | 3 | 4 | 1 −57% | 1 +4% | 1 −59% | 1 −61% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −42.8% 1Y
1Y: ₹6.92 on 10 Sept 2025 → ₹3.96. High ₹7.61 (23 Sept 2025), low ₹3.87 (30 Mar 2026).
Financials, as filed
Revenue grew 24.9% a year over 2 years, FY24 to FY26. Operating margin narrowed to 3.0%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹246 Cr | ₹268 Cr | ₹383 Cr |
| Operating profit | ₹17 Cr | ₹12 Cr | ₹11 Cr |
| Operating margin | 6.8% | 4.6% | 3.0% |
| Interest | ₹1 Cr | ₹1 Cr | ₹2 Cr |
| Depreciation | ₹1 Cr | ₹0 Cr | ₹0 Cr |
| Net profit | ₹11 Cr | ₹8 Cr | ₹7 Cr |
| Net margin | 4.6% | 3.1% | 1.8% |
| Cash from operations | ₹32 Cr | ₹-16 Cr | ₹5 Cr |
| Free cash flow | ₹27 Cr | ₹-18 Cr | ₹4 Cr |
| ROCE | 19.0% | 13.0% | 10.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹4 Cr | ₹4 Cr | ₹13 Cr | ₹38 Cr | ₹38 Cr | ₹38 Cr |
| Reserves | ₹25 Cr | ₹35 Cr | ₹37 Cr | ₹24 Cr | ₹36 Cr | ₹39 Cr |
| Borrowings | ₹25 Cr | ₹37 Cr | ₹46 Cr | ₹20 Cr | ₹2 Cr | ₹37 Cr |
| Other liabilities | ₹13 Cr | ₹10 Cr | ₹8 Cr | ₹15 Cr | ₹4 Cr | ₹18 Cr |
| Total liabilities | ₹67 Cr | ₹86 Cr | ₹103 Cr | ₹96 Cr | ₹80 Cr | ₹131 Cr |
| Fixed assets | ₹2 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹3 Cr | ₹5 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹6 Cr | ₹7 Cr | ₹7 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹4 Cr | ₹0 Cr |
| Other assets | ₹65 Cr | ₹83 Cr | ₹100 Cr | ₹88 Cr | ₹66 Cr | ₹119 Cr |
| Total assets | ₹67 Cr | ₹86 Cr | ₹103 Cr | ₹96 Cr | ₹80 Cr | ₹131 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
The ownership split has held steady since Jun 2025. The shareholder count shrank 1% to 70,737.
- Promoters
- 74.8%
- Public
- 25.2%
Since Jun 2025
- Promoters 0.00 pp
- FIIs 0.00 pp
- Public 0.00 pp
How it drifted, 12 quarters
Ownership split by quarter, oldest first. Sep '23: Promoters 74.8%, Public 25.2%.Dec '23: Promoters 74.8%, Public 25.2%.Mar '24: Promoters 74.8%, FIIs 0.0%, Public 25.2%.Jun '24: Promoters 74.8%, FIIs 0.0%, Public 25.1%.Sep '24: Promoters 74.8%, Public 25.2%.Dec '24: Promoters 74.8%, Public 25.2%.Mar '25: Promoters 74.8%, Public 25.2%.Jun '25: Promoters 74.8%, Public 25.2%.Sep '25: Promoters 74.8%, Public 25.2%.Dec '25: Promoters 74.8%, Public 25.2%.Mar '26: Promoters 74.8%, Public 25.2%.Jun '26: Promoters 74.8%, Public 25.2%.
Who is on the register
Named in the Jun 2026 filing
Every holder of M K Proteins Limited above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Pragun Garg | 6.33% | unchanged |
| Vinod Kumar Huf | 6.23% | unchanged |
| Raj Kumar Garg | 6.19% | unchanged |
| Shivani Garg | 6.11% | unchanged |
| Sunila Garg | 5.71% | unchanged |
| Kamla Finvest Private Limited | 5.61% | unchanged |
| Raj Kumar Garg Huf | 4.65% | unchanged |
| Parvind Kumar | 4.33% | unchanged |
| Shib Charan Dass Industries Private Limited | 4.27% | unchanged |
| Sheel Garg | 4.20% | unchanged |
| Manik Garg | 3.89% | unchanged |
| Neelesh Garg | 3.89% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
What the price assumes
Growth trapTo justify its price of ₹4, this stock must grow earnings at 22% every year for 7 years. Our analysis caps realistic growth at ~-24%. At that growth it is worth ₹0 — downside of 91%.
- Growth the price implies
- 22.0% a year
- for 7 years, fading to 4%
- It has actually compounded at
- -21.7% a year
- net profit, FY24–FY26 · EPS -23.6%
- The gap
- 0.5 pp
- -91% downside if it only repeats history
Learn to analyse M K Proteins Limited
Guides on how to read this kind of business and the numbers that matter.